05.05.2013 Views

full report - UCT - Research Report 2011

full report - UCT - Research Report 2011

full report - UCT - Research Report 2011

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

376<br />

CoNtACt DetAilS<br />

Postal Address: Division of Otolaryngology, Faculty of<br />

Health Sciences, Anzio Road, Observatory, 7925<br />

Tel: +27 21 406 6420<br />

Fax: +27 21 448 8865<br />

<strong>UCT</strong> General enquiries: +27 21 650 9111<br />

<strong>UCT</strong> web: http://www.uct.ac.za<br />

ChriS bArNArD DiviSioN oF<br />

CArDiothorACiC Surgery<br />

heAD oF DiviSioN: ProFeSSor Peter ZillA<br />

Divisional profile<br />

The Division offers the <strong>full</strong> range of adult and paediatric<br />

cardiac and thoracic surgery services, including<br />

all forms of congenital heart disease, myocardial<br />

revascularisation (both on – and off-pump), cardiac<br />

valvular surgery including an active valve repair program<br />

to preserve the patient’s own valves rather than replace<br />

them with prostheses. We also offer thoracic aortic<br />

surgery. The only technologies we do not have access<br />

to are long-term left ventricular assist devices and the<br />

artificial heart both of which are prohibitively expensive<br />

in a developing world situation. We are in the process<br />

of setting up a ‘hybrid operating theatre’ enabling us<br />

to offer the most recent development in heart valve<br />

replacement, namely transcatheter delivered valve<br />

prostheses which in many ways will be the ideal manner<br />

of the replacement of valves in a third world setting.<br />

As this technology is prohibitively expensive special<br />

training-arrangements were entered with the commercial<br />

valve providers to make it affordable under public<br />

hospital circumstances. Moreover, our cardiovascular<br />

research laboratories have been focusing on developing<br />

alternative transcatheter devices specifically aimed<br />

at the needs of a developing country; this includes<br />

collaborative studies with the medical device industry<br />

and other international academic units to allow newer<br />

and more cost-effective devices to become available to<br />

us. In this context, a <strong>UCT</strong> start-up company was formed<br />

around IP developed in the Cardiovascular <strong>Research</strong><br />

Unit, receiving substantial funding – inter alia from the<br />

Department of Science and Technology’s ‘Technology<br />

Innovation Agency’ (TIA).<br />

Divisional profile (cardiovascular research unit)<br />

<strong>2011</strong> saw a final move away from industry funding to<br />

academic grants as our long-term collaboration with a<br />

leading global medical device company came to an end.<br />

The Western Cape Heart <strong>Research</strong> Grouping of the Medical<br />

<strong>Research</strong> Council, of which the Cardiovascular <strong>Research</strong><br />

Unit is a member, was formally reviewed and extended for<br />

another five year term. New collaborative projects between<br />

the Groups members were identified and initiated.<br />

A most significant growth was experienced by our<br />

biomechanics group that has current ongoing grants to the<br />

amount of 5 ½ million Rand.<br />

Our unit is also a participant in Welcome grant in collaboration<br />

with the Department of Medical Biochemistry, and a NRF<br />

grant supporting our research on the biomechanics of<br />

cardiovascular devices. After having been awarded a new<br />

angiography unit for our research laboroatories in 2008<br />

by the NRF we received another major equipment grant<br />

for a state-of-the-art echocardiography machine for our<br />

experimental surgical suite.<br />

<strong>Research</strong> focusing on the cell biology of the process of<br />

neovascularisation has spear-headed our regenerative<br />

medicine approach to facilitating the body’s own ability to<br />

remodel semi-synthetic prostheses. In this regard, a small<br />

animal circulatory vascular model for screening of graft<br />

healing has been <strong>full</strong>y established and is providing very<br />

promising initial results.<br />

Additionally, a model for assessment of the regenerative<br />

capacity of synthetic hydrogels in the treatment of<br />

heart failure induced by myocardial infarction has been<br />

established and has led to published results and interest<br />

from overseas collaborators.<br />

Postgraduate training remained a priority in <strong>2011</strong>.<br />

Interdigitation between our clinical staff and researchers<br />

also remains a key goal for which the Division continues to<br />

strive.<br />

Divisional statistics<br />

permanent and long term contract staff<br />

Professor 1<br />

Associate Professors 4<br />

Senior Consultants 3<br />

Senior lecturer 3<br />

Supernumerary registrars 2<br />

Surgical registrar 4<br />

medical officer 2<br />

Senior Scientific officer 1<br />

Administrative officer 0.5<br />

Secretary 1<br />

Senior medical technologist 2<br />

Clinical technologist/Perfusionist 6<br />

laboratory Assistant 1<br />

total 29.5<br />

<strong>UCT</strong> ReseARCh RepORT '11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!